Using thermal analysis as quality control for famotidine polymorph contamination.
Nenhuma Miniatura disponível
Data
2022
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
It is well known that undesirable polymorphs in active pharmaceutical ingredients, in any proportion, can cause harm, both
fnancially and to the health of patients. Famotidine (FTD) exhibits three known polymorphs, A, B, and C, which difer in
their physicochemical properties. Form B is pharmaceutically preferred because it shows better biopharmaceutical properties.
This study used thermal analysis as the main tool in the quality control of polymorphs in FTD batches. The impact on solubil-
ity, polymorphic stability, and dissolution profle of tablets was also studied. One batch (called F01), of fve characterized,
showed contamination with polymorph A. F01 was ~2.6 times less soluble than the pure form B batch (called F05) in pH
4.5 phosphate bufer, the recommended US Pharmacopoeia dissolution medium for FTD tablets. Moreover, it was observed
that after storage for 3 months (40±2 °C and RH of 75±5%), F05 also showed contamination with form A, representing a
risk that should be monitored during the quality control of FTD raw materials and drug formulations. Nevertheless, tablets
manufactured with these batches did not show diferences in their dissolution profles, indicating that the amount of form A
found in F01 was not sufcient to alter release of the drug from the formulated tablet. Therefore, thermal analysis is efcient
in detecting polymorphic contaminations of FTD raw materials, suggesting adequate and fast methods for quality control of
drug products and thus, avoiding compromised therapeutic efcacy.
Descrição
Palavras-chave
Solubility, Polymorphic stability
Citação
FREITAS, J. T. J. et al. Using thermal analysis as quality control for famotidine polymorph contamination. Journal of Thermal Analysis and Calorimetry, v. 147, p. 13405-13412, 2022. Disponível em: <https://link.springer.com/article/10.1007/s10973-022-11667-z>. Acesso em: 01 ago. 2023.